KRAS and colorectal carcinoma: A number of studies [14–18] suggest that glucose accumulation in PET/CT is significantly associated with genetic mutations (KRAS, KRAS/BRAF, or KRAS/NRAS) in primary CRC, metastatic CRC, or rectal cancer.